JACOBS LEVY EQUITY MANAGEMENT, INC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 189 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$242,188
-10.5%
403,782
+94.1%
0.00%
-50.0%
Q2 2023$270,462
-70.6%
208,048
-60.1%
0.00%
-66.7%
Q1 2023$918,704
+149.0%
521,991
+344.2%
0.01%
+200.0%
Q4 2022$369,026
-42.0%
117,524
-9.4%
0.00%
-60.0%
Q3 2022$636,000
+55.1%
129,789
+31.1%
0.01%
+66.7%
Q2 2022$410,000
-38.3%
99,010
+144.2%
0.00%
-75.0%
Q4 2017$665,000
+41.5%
40,540
+29.4%
0.01%
+33.3%
Q3 2017$470,00031,3400.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders